Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design pubmed.ncbi.nlm.nih.gov/35468332/
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 cdc.gov/mmwr/volumes/7…
上記の報告内に出てくる表を貼り付けます。
本文内では全く論じられていませんが、この表データから、単価ワクチン4回接種 vs ワクチン未接種でVEを自分で計算してみました。
test negative designとして、VE= (1-OR)で算出。
A post-marketing safety assessment of COVID-19 mRNA vaccination for serious adverse outcomes using administrative claims data linked with vaccination registry in a city of Japan sciencedirect.com/science/articl…